Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

Meet Us at PEGS 2018

PEGS: The The Essential Protein Engineering Summit brings the brightest minds in biotherapeutics protein drug development together under one roof! We are thrilled to be attending PEGS 2018 this year in Boston. Attending PEGS? See Us At Booth 201 Be sure to visit us at Booth 201 to see our latest immune cell products and…

Cells in Motion: PBMC Research

Peripheral blood mononuclear cells (PBMC) play an essential role in immunology research. Three publications recently featured PBMC from Astarte Biologics to study a Zika virus vaccine and T cell immunotherapy methods. A DNA Vaccine Protects Human Immune Cells against Zika Virus Infection in Humanized Mice Guohua et al. found that a Zika virus vaccine elicited…

A Guide to Laboratory Biosafety Levels

The American Biological Safety Association (ABSA) sets the standard for biosafety levels and laboratory requirements in the United States. To mitigate the risk of infection and contamination from pathogenic microorganisms, the ABSA has developed four distinct biosafety levels that, when properly implemented, should contain harmful biological agents and prevent contamination. What Biosafety Level Should My…